Thanks Mozz. Great job. It's hard not to get excited about the last bit! Those biomarker readings are really significant because they support the WOMAC results by showing why comfort and utility is enhanced in patients. If this data continues BF will leap at the chance to license it. Six month results could be transformative.
Ann: Paradigm AGM Presentation, page-25
-
- There are more pages in this discussion • 117 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.010(4.44%) |
Mkt cap ! $78.73M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 24.0¢ | 22.5¢ | $125.6K | 540.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 71028 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 136446 | 8 |
View Market Depth
| Last trade - 12.21pm 13/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |